New drug duo tested for Tough-to-Treat head and neck cancers
NCT ID NCT03082534
Summary
This study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was to see how many patients' tumors shrank in response to the combination therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
-
University of California Los Angeles Cancer Center
Los Angeles, California, 90095, United States
-
University of Michigan Cancer Center
Ann Arbor, Michigan, 48109, United States
-
Washington School of Medicine Cancer Center
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.